Raquel Carvalho Bouth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Raquel Carvalho Bouth has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Ana Caroline Cunha Messias
Dermato‐Immunology Laboratory Federal University of Pará Marituba Pará Brazil
1 shared publicationAngélica Rita Gobbo
Dermato‐Immunology Laboratory Federal University of Pará Marituba Pará Brazil
1 shared publication- Claudio Guedes Salgado
Laboratório de Dermato-Imunologia, Universidade Federal do Pará, Marituba, Pará, Brazil
1 shared publication - Erika Vanessa Oliveira Jorge
Dermato‐Immunology Laboratory Federal University of Pará Marituba Pará Brazil
1 shared publication - Izabelle Laissa Viana Costa
Dermato‐Immunology Laboratory Federal University of Pará Marituba Pará Brazil
1 shared publication - John Stewart Spencer
Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA
1 shared publication
Latest Publications
- Open Access
- 3 July 2025
- Published by Wiley in Tropical Medicine & International Health
- Vol. 30 (9) , 1018-1022
Leprosy in blood donors
Objectives: We investigated the prevalence of anti‐phenolic glycolipid‐I (PGL‐I) IgM antibodies among temporarily unfit blood donors at the Pará State Blood Bank (HEMOPA), located in the Amazon region of northern Brazil. Using an arbitrary high cutoff for optical density (OD ≥0.750) in ELISA, a subset of donors was invited for clinical evaluation for leprosy.Methods: Temporarily unfit individuals were invited to participate, and blood samples were collected for anti‐PGL‐I IgM titration by ELISA. Donors with high OD values were referred for clinical examination, slit skin smear (SSS) bacilloscopy, and quantitative PCR (qPCR) targeting M. leprae‐specific repetitive element (RLEP) sequences from dermal scrapes of the earlobes and peripheral blood.Results: From an annual average of 2762 temporarily unfit donors (2019–2023), 500 (16.6%) were tested for anti‐PGL‐I IgM. Of these, 20/500 (4.0%) had high antibody titres, and 8/20 (40.0%) attended clinical evaluation, resulting in 5/8 (62.5%) newly diagnosed cases of leprosy. Among these, Mycobacterium leprae detection yielded positivity rates of 2/8 (25.0%) by SSS bacilloscopy, 3/7 (42.9%) by qPCR of dermal scrapes, and 2/8 (25.0%) by qPCR of peripheral blood.Conclusions: Using an anti‐PGL‐I IgM cutoff of OD ≥0.750, we identified a significant proportion of undiagnosed leprosy cases among temporarily unfit blood donors. These findings support the need for targeted leprosy screening in this population. Regardless of qPCR results, individuals with clinical signs of leprosy require appropriate treatment and assessment of their eligibility for blood donation.
- 3 July 2025
- Published by Wiley in Tropical Medicine & International Health
- Vol. 30 (9) , 1018-1022
Open AccessLeprosy in blood donors
Objectives: We investigated the prevalence of anti‐phenolic glycolipid‐I (PGL‐I) IgM antibodies among temporarily unfit blood donors at the Pará State Blood Bank (HEMOPA), located in the Amazon region of northern Brazil. Using an arbitrary high cutoff for optical density (OD ≥0.750) in ELISA, a subset of donors was invited for clinical evaluation for leprosy.Methods: Temporarily unfit individuals were invited to participate, and blood samples were collected for anti‐PGL‐I IgM titration by ELISA. Donors with high OD values were referred for clinical examination, slit skin smear (SSS) bacilloscopy, and quantitative PCR (qPCR) targeting M. leprae‐specific repetitive element (RLEP) sequences from dermal scrapes of the earlobes and peripheral blood.Results: From an annual average of 2762 temporarily unfit donors (2019–2023), 500 (16.6%) were tested for anti‐PGL‐I IgM. Of these, 20/500 (4.0%) had high antibody titres, and 8/20 (40.0%) attended clinical evaluation, resulting in 5/8 (62.5%) newly diagnosed cases of leprosy. Among these, Mycobacterium leprae detection yielded positivity rates of 2/8 (25.0%) by SSS bacilloscopy, 3/7 (42.9%) by qPCR of dermal scrapes, and 2/8 (25.0%) by qPCR of peripheral blood.Conclusions: Using an anti‐PGL‐I IgM cutoff of OD ≥0.750, we identified a significant proportion of undiagnosed leprosy cases among temporarily unfit blood donors. These findings support the need for targeted leprosy screening in this population. Regardless of qPCR results, individuals with clinical signs of leprosy require appropriate treatment and assessment of their eligibility for blood donation.